Transparency Market Research
is Published new Market Report “Drugs
of Abuse Testing Market (Sample Based Testing – Urine, Saliva and Hair
Onsite and laboratory Testing) – Global Industry Analysis, Size, Share, Growth,
Trends and Forecast, 2013 – 2018″ the global drugs of abuse testing
market was valued at USD 2.6 billion in 2012 and is expected to grow at a CAGR
of 4.8% from 2013 to 2018, to reach an estimated value of USD 3.4 billion in
2018.
In various countries,
government rules & regulations are supporting drugs of abuse testing market
to grow, as they have outlined essential drug testing at workplace, such as in
the US, Japan, Australia and the UK. As a result, this market is expected to
grow at a CAGR of about 4.8% during 2013 – 2018.
Some of the key driving
factors for the drugs of abuse testing market are global rising consumption of
illicit drugs, adoption of drug of abuse (DOA) testing at organizational level,
increased production of illicit drugs and their trade and increasing death
rates/road accidents due to drug abuse. However, the market faces some
restraints such as social concerns associated with illicit drugs testing,
legalization of various drugs, and economic volatility and cost concerns.
North America, including the
US has the largest drugs of abuse testing market and is also the fastest
growing drugs of abuse testing market. Some of the fastest growing markets
for drugs of abuse testing are US, UK, Japan, Germany and other European
countries. According to UNODC report 2013, number of illicit drug users is
estimated to increase from 167 million in 2009 to 315 million people in 2011.
This corresponds to 3.6% to 6.9% of global adult population and cannabis,
opioids and opiates were most commonly used illicit drugs. In various
countries, including America and Europe countries, organizations are conducting
drug screening test at various levels, such as pre-employment screening, random
drug/alcohol screening, post incident drug/alcohol screening and abstinence
monitoring. In many countries, government rules & regulations are also supporting
the growth of drugs of abuse testing market, as they have outlined essential
drug testing at workplace, such as in the US, Japan, Australia and the UK. This
has emerged as a key driver for
the market.
Browse the full Report with TOC: http://www.transparencymarketresearch.com/drugs-abuse-testing-market.html
Urine is the largest sample
which is diagnosed in the drugs of abuse testing market and it is expected to
grow at a CAGR of about XX% during 2013 – 2018. The other major samples for
drugs of abuse testing are Saliva and Hair. Laboratory drug screening test
requires a trained and skilled person to provide an accurate result and
involves in-depth analysis. In laboratory screening test, usually the test is
reconfirmed using gas chromatography/mass spectrometry or any other superior
techniques to provide accurate results. On-site drug screening test gives results
on the spot and it is generally preferred for those who take the drug test at
home, workplace and educational institutions. The most common specimens used in
on-site drug testing are urine, saliva and hair. Nowadays,
commercially-available on-site screening test kits are usually designed for
urine and saliva specimens only.
Roche Diagnostics is the
leading player in the global drugs of abuse testing market. Other major players
of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and
Abbott Laboratories and others.
The global drugs of abuse
testing market is segmented as follows:
Drugs of Abuse Testing Market, By Sample
·
Urine
·
Saliva
·
Hair
Drugs of Abuse Testing Market, By Types
·
Laboratory Drug
Test
·
On-site Screening
Test
Drugs of Abuse Testing Market, by Geography
·
North America
·
US
·
Europe
·
UK
·
Germany
·
France
·
Asia Pacific
·
Japan
·
China
·
India
·
Rest of the World
(RoW)
Related
Blog : http://medicaldevicesnews.wordpress.com
No comments:
Post a Comment